Scott Van Winkle


Canaccord Genuity Reiterates Hold On USANA Health Sciences, $78 PT

In a research report issued today, Canaccord Genuity analyst Scott Van Winkle reiterated a Hold rating on USANA Health Sciences (NYSE:USNA) with a …

Canaccord Genuity Maintains Buy On Herbalife Shares, $73 PT

In a research report issued today, Canaccord Genuity analyst Scott Van Winkle maintained a Buy rating on Herbalife Ltd (NYSE:HLF) with a price …

Canaccord Genuity Maintains Hold On Medifast, $29 PT

In a research report issued today, Canaccord Genuity analyst Scott Van Winkle maintained a Hold rating on Medifast (NYSE:MED) with a price target …

Canaccord Genuity Assigns Hold On Nu Skin Enterprises Shares, $53 PT

In a research report issued yesterday, Canaccord Genuity analyst Scott Van Winkle assigned a Hold rating on Nu Skin Enterprises (NYSE:NUS) with a …

Canaccord Raises Hain Celestial Price Target To $112

In a research note released today, Canaccord analyst Scott Van Winkle maintained a Buy rating on Hain Celestial Group (NASDAQ:HAIN) and raised his …

Canaccord Reiterates Buy On Keurig Green Following Licensing Agreement With Kraft Foods

In a report published August 22, analyst Scott Van Winkle of Canaccord reiterated a Buy rating on Keurig Green Mountain (NASDAQ:GMCR) and raised his price target by 10% to $134 (from $122) …

Canaccord Maintains Buy On Hain Celestial Following Solid 4Q14 And Guides Above For F2015

In a research note released today, Canaccord analyst Scott Van Winkle maintained a Buy rating on Hain Celestial Group (NASDAQ:HAIN) with a $108 price target, following the company’s fourth-quarter …

Canaccord Raises Price Target On Medifast; Expects Improved Profitability

In a research note released today, Canaccord analyst Scott Van Winkle maintained his Hold position on Medifast (MED) and upgraded his price target to $32.00 from $31.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts